Exit Right 2023: From start-up to exiting to a global pharmaceutical company
Come and hear the real-life story of start-up to exit from David Llewellyn, Managing Director and Co-Founder of Oxford-based biotech company, DJS Antibodies.
Come and hear the real-life story of start-up to exit from David Llewellyn, Managing Director and Co-Founder of Oxford-based biotech company, DJS Antibodies.
Hear the personal stories of two very different types of exit. CEO, Matthew Walls from predictive genetics company, GENinCode, will share experiences of his exit via an Initial Public Offering (IPO) and the transition from a private to a public company and what that entailed.
There are lots of factors to consider when deciding whether to grow or sell your business. Our guest speakers will share their experiences of successful growth strategies and tips for acquisitions and business exit, with real life dilemmas and advice.
In order to prepare for exit, it is important to create a business that purchasers are excited to buy. So, what exactly is a purchaser looking for and what can you do to increase your chances of success?